Two Sigma Securities’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$302K Buy
+510
New +$254K 0.04% 771
2025
Q4
Sell
-2,790
Closed -$1.17M 2043
2025
Q3
$1.17M Buy
2,790
+2,046
+275% +$688K 0.17% 136
2025
Q2
$214K Buy
+744
New +$222K 0.03% 883
2024
Q3
Sell
-1,429
Closed -$483K 3666
2024
Q2
$455K Buy
1,429
+70
+5% +$18.5K 0.01% 1627
2024
Q1
$312K Buy
1,359
+272
+25% +$61.4K ﹤0.01% 1930
2023
Q4
$239K Sell
1,087
-77
-7% -$17.7K ﹤0.01% 2220
2023
Q3
$263K Buy
+1,164
New +$268K ﹤0.01% 2064
2023
Q2
Sell
-1,781
Closed -$394K 3375
2023
Q1
$399K Buy
1,781
+1,047
+143% +$258K 0.01% 1430
2022
Q4
$204K Buy
+734
New +$185K 0.01% 1937
2022
Q3
Sell
-3,135
Closed -$739K 3130
2022
Q2
$739K Buy
+3,135
New +$637K 0.03% 683
2021
Q4
Sell
-1,174
Closed -$217K 2076
2021
Q3
$217K Buy
+1,174
New +$231K 0.01% 1192
2019
Q2
Sell
-2,349
Closed -$276K 2438
2019
Q1
$276K Buy
+2,349
New +$274K ﹤0.01% 1254
2018
Q4
Sell
-1,651
Closed -$211K 2866
2018
Q3
$211K Buy
+1,651
New +$204K ﹤0.01% 2089
2017
Q3
Sell
-2,689
Closed -$349K 1234
2017
Q2
$349K Buy
+2,689
New +$335K 0.07% 302
2015
Q4
Sell
-1,610
Closed -$211K 372
2015
Q3
$211K Buy
+1,610
New +$258K 0.33% 124

Other funds holding UTHR

Two Sigma Securities's UTHR Position: Q1 2026 in Review

Two Sigma Securities opened a new position in United Therapeutics (UTHR) in Q1 2026: 510 shares worth $302K. The stake represents 0.04% of the portfolio and ranks #771 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in UTHR as recently as Q3 2025.

Two Sigma Securities first reported a position in UTHR in Q3 2015 and has held it in 15 quarters since. The position peaked at $1.17M in Q3 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Two Sigma Securities held 510 shares of United Therapeutics worth $302K as of Q1 2026.
  • United Therapeutics was a new Two Sigma Securities position in Q1 2026.
  • United Therapeutics made up 0.04% of Two Sigma Securities's portfolio in Q1 2026, its #771 holding.
  • Two Sigma Securities first reported a position in United Therapeutics in Q3 2015 and has held it in 15 quarters since.
  • Two Sigma Securities's United Therapeutics position peaked at $1.17M in Q3 2025.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.